<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Life Sciences</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/72265151-89A7-450E-A15F-F2080AD38054"><gtr:id>72265151-89A7-450E-A15F-F2080AD38054</gtr:id><gtr:firstName>Susan</gtr:firstName><gtr:otherNames>Jane</gtr:otherNames><gtr:surname>Kimber</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F785B423-CFB6-4A4C-B8BA-802DC65552DB"><gtr:id>F785B423-CFB6-4A4C-B8BA-802DC65552DB</gtr:id><gtr:firstName>Daniel</gtr:firstName><gtr:otherNames>R</gtr:otherNames><gtr:surname>Brison</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FJ021636%2F1"><gtr:id>18DD7E68-FC31-4465-B0F1-9922841BCF0D</gtr:id><gtr:title>Expandable Clinical Grade Feeder Cells for hESc Derivation</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/J021636/1</gtr:grantReference><gtr:abstractText>We aim to generate an inexhaustible supply of immortalised clinical grade human dermal fibroblasts (hDFs) for derivation of cGMP hESc lines. Human Embryonic stem cells (hESc) have great potential for use in clinical therapies but current hESc lines have not been generated under conditions suitable for clinical use. We will exploit our successful TSB-funded feasibility study to generate suitable immortalised human dermal fibroblasts (hDFs) for derivation of cGMP hESc lines. We will immortalise 2 primary (clinical grade) hDF lines, already shown to support culture and derivation of cGMP hESc lines in a unique media system, using a method shown by us to generate hESc-supportive feeder cells at the research level. The immortalised cells will be tested for derivation of new cGMP hESc lines and will provide a supply of marketable cGMP feeder cells for use in generating hESc for therapy.</gtr:abstractText><gtr:technicalSummary>We aim to generate an inexhaustible supply of immortalised clinical grade human dermal fibroblasts (hDFs) for derivation of cGMP hESc lines. Human Embryonic stem cells (hESc) have great potential for use in clinical therapies but current hESc lines have not been generated under conditions suitable for clinical use. We will exploit our successful TSB-funded feasibility study to generate suitable immortalised human dermal fibroblasts (hDFs) for derivation of cGMP hESc lines. We will immortalise 2 primary (clinical grade) hDF lines, already shown to support culture and derivation of cGMP hESc lines in a unique media system, using a method shown by us to generate hESc-supportive feeder cells at the research level. The immortalised cells will be tested for derivation of new cGMP hESc lines and will provide a supply of marketable cGMP feeder cells for use in generating hESc for therapy.</gtr:technicalSummary><gtr:potentialImpactText>HESc are envisioned to play a major future role in the RM industry with market potentials in the region of $100 billion (MaRS report 2009). For this impact to be realised, of the many advances needed, one critical step is the ability to derive and grow clinical grade hESc which can be targeted to desired target cells. We seek to fill this gap in the RM market by producing xeno-free immortalised human feeder cells of validated ability to support derivation of hESc under stringent clinically acceptable conditions. Since there are no commercial sources of expandable xeno-free cGMP human feeder cells suitable for hESc growth and derivation that can be used as an alternative, what we propose is a unique opportunity to enhance UK and Europe's RM and possibly that outside Europe. Biotime (US) market only animal product-exposed hDFs which are not immortalised and thus not a significantly expandable supply as they carry the risk of losing their supportive ability with increased expansion. Our expandable cells will likely also function for the generation and culture of ES-like cells derived from somatic tissue (induced pluripotent somatic, ips, cells) which might form an alternative source of tissue for clinical therapy in the future. Critically, the further development of the hDF feeder lines through our immortalisation method will lead to a unique and fully expandable source of cells for commercial exploitation and this will be promoted and marketed commercially through the activities of XCellR8.</gtr:potentialImpactText><gtr:fund><gtr:end>2014-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2012-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>142036</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Science Media Centre press conference</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E2239E68-CFF2-4E1E-95A6-2223AD6738BD</gtr:id><gtr:impact>Press conference organised by SMC to discuss press release concerning submission of clinical grade embryonic stem cell lines to the UK Stem Cell Bank

Interest from media, followup stories. Followup contacts from industry resulting directly from press release.</gtr:impact><gtr:outcomeId>RS1hsH2BEqL</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>New Scientist Article on ART child health</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B94CB072-DAFC-4A71-9752-6C2BF78FDC71</gtr:id><gtr:impact>Interview for article in New Scientist on research into ART child health</gtr:impact><gtr:outcomeId>56ddeb57a83b74.45824920</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Guardian newspaper article on ART child health</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>62514556-3F5B-414E-8652-CD7F485EE5A6</gtr:id><gtr:impact>Guardian newspaper article on ART child health</gtr:impact><gtr:outcomeId>56ddecf3cf1a48.66372587</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CMFT Xmas lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>6DB85384-526D-45B4-8563-2A882FCD4196</gtr:id><gtr:impact>Xmas Royal Society-style lecture for Central Manchester NHS Foundation Trust &amp;quot;The Stem Cell Revolution&amp;quot;.

School visit requests</gtr:impact><gtr:outcomeId>54638c99079904.93253963</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio 4 interview re 'Promising' stem cell trials for blindness</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>90179E84-93F8-40B4-AAB5-253DAD3FFC3E</gtr:id><gtr:impact>Daniel Brison interviewed and commented on news story re stem cell therapies

Raising public awareness</gtr:impact><gtr:outcomeId>D64dC6mLWBJ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited lecture to EU Student Parliament debate on embryo research</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7DAFFC1B-307C-4E41-B68D-D939A5DD6908</gtr:id><gtr:impact>Invited lecture to EU Student parliament debate on human embryo research including embryonic stem cell derivation, in Salford, UK</gtr:impact><gtr:outcomeId>58c2cc3d81d642.34282301</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Membership of HFEA's Scientific and Clinical Advances Advisory Committee</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D0458B1B-B772-403B-901A-C2D05A213C54</gtr:id><gtr:impact>Membership of HFEA's Scientific and Clinical Advances Advisory Committee</gtr:impact><gtr:outcomeId>56ddec29aee746.47408668</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>Pre-2006,2006,2007,2008,</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio 4 interview with Mark Porter</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>49B2B45C-F43E-49B9-AD87-F1B6B0FCF35E</gtr:id><gtr:impact>Sue Kimber interviewed on Radio 4 Case Notes programme re stem cell therapies

Raised public awareness, led to doubled patient and GP interest in NWESCC</gtr:impact><gtr:outcomeId>BTUKp2y9J24</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lancashire Humanists</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>63942C8E-A9E4-4A33-A7A3-D884A944A5D9</gtr:id><gtr:impact>70 people attenced a public lecture on stem cell biology

Requests for other talks to Humanist groups.</gtr:impact><gtr:outcomeId>YMajzoRVuaG</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Membership of HFEA's Information for Quality Programme</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EF4E9324-3B70-4E1D-9379-B444836EC09E</gtr:id><gtr:impact>Membership of HFEA's Information for Quality Programme</gtr:impact><gtr:outcomeId>56ddebc7db4261.70184186</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>285607</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>EpiHealthNet</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>C937B04C-20EC-4EFC-A91A-542492C35ECC</gtr:id><gtr:outcomeId>BUWjKm7HvNm</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>570000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Diabetes UK</gtr:description><gtr:end>2018-10-02</gtr:end><gtr:fundingOrg>Diabetes UK</gtr:fundingOrg><gtr:id>23C67AD4-4316-4E27-8967-5CF66A5CFB2A</gtr:id><gtr:outcomeId>56dde3c93b1d21.89024504</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>793000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Chondrocytes from clinical grade embryonic stem cells</gtr:description><gtr:end>2017-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L004992/1</gtr:fundingRef><gtr:id>F9BE86F1-75C9-452B-88E7-76835072821E</gtr:id><gtr:outcomeId>54636c78631606.93067965</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>700000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EME - EFREEZE</gtr:description><gtr:end>2018-07-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>AD5BC6DA-4348-4B71-9715-7A05A7A8D024</gtr:id><gtr:outcomeId>54636acfd39497.99464740</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1290000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC project grant</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/M017354/1</gtr:fundingRef><gtr:id>12D03251-24B0-4822-9FBB-7D707608F161</gtr:id><gtr:outcomeId>56dde5b09b9aa1.93333904</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>251813</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Stoneygate Feehally reserch award</gtr:description><gtr:end>2020-04-02</gtr:end><gtr:fundingOrg>Kidney Research UK</gtr:fundingOrg><gtr:id>9BF7DEF0-576C-4C60-A21E-A29B7AAD4E89</gtr:id><gtr:outcomeId>58bb15f5db72d7.07439314</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>110000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC icase studentship (with Argo)</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>39ADFFC2-977F-4B06-9EA0-6A24989CB7DD</gtr:id><gtr:outcomeId>546369cf90f217.69073626</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>270000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Clinical fellowship</gtr:description><gtr:end>2021-05-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>D38CE4B0-21AB-440B-8264-12BE2539BA44</gtr:id><gtr:outcomeId>56dde48f1c97f3.35792053</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UK national ART cohort - Population and Systems Medicine Board</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L020335/1</gtr:fundingRef><gtr:id>7F37C0CF-1A66-4812-A386-471F57456BF2</gtr:id><gtr:outcomeId>546367d6a79c04.59498648</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Toxicology programme</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>61652DFB-85F0-4B8C-AEEB-46BC9497E376</gtr:id><gtr:outcomeId>546369685a62f5.37018931</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EME - HaBSelect</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>A45DCFB6-297D-4955-A7D7-B67DCE7B41BD</gtr:id><gtr:outcomeId>54636a72020ab8.60854298</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Our validation of feeder cells allowed these to be used by UK Stem Cell Bank for support of other hESC GMP lines as well as our own</gtr:description><gtr:firstYearOfImpact>2014</gtr:firstYearOfImpact><gtr:id>B28A9FA1-1AC3-4246-87FA-DD1B0B684345</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56d708de66bf07.95359730</gtr:outcomeId><gtr:sector>Healthcare</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We generated untransfected and immortlised human fibroblast feeders suitable for clinical grade pluripotent stem cell support and maintenace, which are used by us and the UKSTEM cell bang a swellas in other research organisations.</gtr:description><gtr:exploitationPathways>To support GMP grade pluripotent stem cells for clinical use</gtr:exploitationPathways><gtr:id>51961DEA-40D8-4FD2-A68D-77DBC8B8EE28</gtr:id><gtr:outcomeId>56d709771b5147.45517117</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>ESHRE working group on the impact of embryo culture medium on long term health</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>9C179ED9-E13B-44E4-BED0-D86381327C84</gtr:id><gtr:outcomeId>56def2c72e6bf9.57948647</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Membership of HFEA's Scientific and Clinical Advances committee</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B7C9CE04-F0C8-45A8-B8F8-F357293DEBAA</gtr:id><gtr:impact>Advising the HFEA on changes in regulation on embryology and embryonic stem cell biology</gtr:impact><gtr:outcomeId>enWpVaz3Rgt</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of TERMIS Scientific Advisory Board</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>76786F6C-76B4-4A23-81A1-1D30D25A1D13</gtr:id><gtr:outcomeId>magqDeYGPsY</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>National Clinical human Embryonic Stem Cell Forum</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A7256932-7BC7-4AA9-9B76-402A7B7D49FA</gtr:id><gtr:impact>Standardisation of requirements for clinical grade embryonic stem cell lines. Prof Brison is vice-chair of this group</gtr:impact><gtr:outcomeId>JDzv2iuj9pu</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Cochrane guideline on embryo culture temperature</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>9BE77DA2-EF58-4A70-AE0D-15056EB77196</gtr:id><gtr:outcomeId>56def31820d975.88069617</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>HFEA Information for Quality programme</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C2DCDCA0-F504-4E59-A091-21773F5D4FFA</gtr:id><gtr:impact>acting as advisor to Human Fertilisation and Embryology Authority Information for quality programme which aims to improve regulatory oversight of the field including stem cell derivation, and improve information to patients and for delivery of clinical IVF services.</gtr:impact><gtr:outcomeId>5463b792049bb2.03091056</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Influencing policy towards patenting of discoveries using hESC lines</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>72EF7FDF-CA19-46ED-89E1-8BE5CFD8FB14</gtr:id><gtr:outcomeId>rSU1QnSGJkR</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Setting standards for procurement of embryonic stem cells at clinical grade</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C7CB7EE3-B338-4429-9F44-A3928C2B6738</gtr:id><gtr:outcomeId>YykAiDHyyri</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Stem Cells for Safer Medicine Panel Member</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3488BCA3-0649-4D4D-8917-C1392FC6B9CB</gtr:id><gtr:outcomeId>myxbn9Peruf</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Manchester Clinical grade hESCs now registered as EUCTD compliant and launched by Stem Cell bank</gtr:description><gtr:id>727B118E-02A5-4453-8DA0-078E13A54B2E</gtr:id><gtr:impact>Provision at research grade lines in in 2015. Lead to several papers from Hay and Kunath groups. Now available as clinical grade though UKSCB</gtr:impact><gtr:outcomeId>58bb2d95c5f793.56255733</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Six Clinical grade Manchester hESC lined completed due diligence and made avialble by UKSCB</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>immortalisation of GMP grade fibroblasts under clean room conditions</gtr:description><gtr:id>DFC6633B-CCA0-49B3-A68F-3E658EE20F58</gtr:id><gtr:impact>Research advance and help to UKSCB</gtr:impact><gtr:outcomeId>56ddcdcc43e1a6.75194549</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>immortalisation of GMP grade fibroblasts under clean room conditions</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>04E779AF-DF06-4AE7-9C21-A82C0028DE16</gtr:id><gtr:title>ACE consensus meeting report: oocyte and embryo cryopreservation Sheffield 17.05.11.</gtr:title><gtr:parentPublicationTitle>Human fertility (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f9e96ff3845365a47234edf4e05a8ff"><gtr:id>1f9e96ff3845365a47234edf4e05a8ff</gtr:id><gtr:otherNames>Brison D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1464-7273</gtr:issn><gtr:outcomeId>56d9cc54b57991.70372026</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5682F561-3FD9-41E1-8D60-537A8EDE4330</gtr:id><gtr:title>Metabolic heterogeneity during preimplantation development: the missing link?</gtr:title><gtr:parentPublicationTitle>Human reproduction update</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35fd3108133ce098bcd90592e68f235a"><gtr:id>35fd3108133ce098bcd90592e68f235a</gtr:id><gtr:otherNames>Brison DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1355-4786</gtr:issn><gtr:outcomeId>546362cc152139.43556606</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FFB2C4C3-65A9-472F-A6DB-6C08928EACCF</gtr:id><gtr:title>Cartilage repair using human embryonic stem cell-derived chondroprogenitors.</gtr:title><gtr:parentPublicationTitle>Stem cells translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8bc25f202f0a7e25ac3d6deaad2005b"><gtr:id>d8bc25f202f0a7e25ac3d6deaad2005b</gtr:id><gtr:otherNames>Cheng A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2157-6564</gtr:issn><gtr:outcomeId>5463642c2e2f32.44160384</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDF6F70C-7309-441D-A2D6-3303FFE6D68A</gtr:id><gtr:title>Derivation of the human embryonic stem cell line RCM1.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba0b6035e4458fc14d9c61658be76e45"><gtr:id>ba0b6035e4458fc14d9c61658be76e45</gtr:id><gtr:otherNames>De Sousa PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>58c2c274730242.97959541</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ADAA1009-C88B-446D-9883-992A10FFFA32</gtr:id><gtr:title>Factors affecting embryo viability and uterine receptivity: insights from an analysis of the UK registry data.</gtr:title><gtr:parentPublicationTitle>Reproductive biomedicine online</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9d5e9177843ea6bcf4fb1b7418b0653"><gtr:id>e9d5e9177843ea6bcf4fb1b7418b0653</gtr:id><gtr:otherNames>Roberts SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1472-6483</gtr:issn><gtr:outcomeId>56d9cc52adf7e5.49817140</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA37DA35-1D89-426C-AADF-252D44844C28</gtr:id><gtr:title>Corrigendum: Graphene Oxide promotes embryonic stem cell differentiation to haematopoietic lineage.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8bc335b9058c25ae59c2c91c49d66f3"><gtr:id>a8bc335b9058c25ae59c2c91c49d66f3</gtr:id><gtr:otherNames>Garcia-Alegria E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58bb1d959d03c4.65748597</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>920EB87E-4C5B-43B5-A6C4-41C2B02A3A7B</gtr:id><gtr:title>Comparison of gene expression in fresh and frozen-thawed human preimplantation embryos.</gtr:title><gtr:parentPublicationTitle>Reproduction (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38baf0b6e80f9ea2fe8e09a071e833f6"><gtr:id>38baf0b6e80f9ea2fe8e09a071e833f6</gtr:id><gtr:otherNames>Shaw L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1470-1626</gtr:issn><gtr:outcomeId>pm_15264_24_22996807</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9AFB9899-6CD7-456D-87FE-D525A59D79A4</gtr:id><gtr:title>Global gene expression profiling of individual human oocytes and embryos demonstrates heterogeneity in early development.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38baf0b6e80f9ea2fe8e09a071e833f6"><gtr:id>38baf0b6e80f9ea2fe8e09a071e833f6</gtr:id><gtr:otherNames>Shaw L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15264_24_23717564</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CA551C1-D272-48E1-A29F-EFA2BA6B15AE</gtr:id><gtr:title>How should we assess the safety of IVF technologies?</gtr:title><gtr:parentPublicationTitle>Reproductive biomedicine online</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35fd3108133ce098bcd90592e68f235a"><gtr:id>35fd3108133ce098bcd90592e68f235a</gtr:id><gtr:otherNames>Brison DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1472-6483</gtr:issn><gtr:outcomeId>pm_15264_24_24145118</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58DCAC1A-8EBC-4E30-82B3-E9C667D45DFD</gtr:id><gtr:title>Optimized protocol for derivation of human embryonic stem cell lines.</gtr:title><gtr:parentPublicationTitle>Stem cell reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aeeddc0f73525a60b36da7bf0b7dbad5"><gtr:id>aeeddc0f73525a60b36da7bf0b7dbad5</gtr:id><gtr:otherNames>Camarasa MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1550-8943</gtr:issn><gtr:outcomeId>pm_15264_24_22614996</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EFD051E3-7638-4985-9DD0-F97E397DC8E0</gtr:id><gtr:title>Polymer Supported Directed Differentiation Reveals a Unique Gene Signature Predicting Stable Hepatocyte Performance.</gtr:title><gtr:parentPublicationTitle>Advanced healthcare materials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88faafb158d268b797c8d4d26509a188"><gtr:id>88faafb158d268b797c8d4d26509a188</gtr:id><gtr:otherNames>Villarin BL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2192-2640</gtr:issn><gtr:outcomeId>5675e7477f915</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F88B951-089B-422B-9B9A-0C57BC68722C</gtr:id><gtr:title>The Molecular Karyotype of 25 Clinical-Grade Human Embryonic Stem Cell Lines.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93977d2ba9fe935c99b3418690c14eaf"><gtr:id>93977d2ba9fe935c99b3418690c14eaf</gtr:id><gtr:otherNames>Canham MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56d9cc52d88874.18293894</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB193E30-24C1-4530-B87D-FF97CB51976E</gtr:id><gtr:title>Time to take human embryo culture seriously.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ea5b5fbc9b3dced0d706343485c6bd9"><gtr:id>1ea5b5fbc9b3dced0d706343485c6bd9</gtr:id><gtr:otherNames>Sunde A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn><gtr:outcomeId>58c2c2741c1f75.64881741</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BD0B09B-2F24-443E-8057-5D2455FE47DD</gtr:id><gtr:title>High&amp;nbsp;quality clinical&amp;nbsp;grade human embryonic stem cell lines derived from fresh discarded embryos.</gtr:title><gtr:parentPublicationTitle>Stem cell research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a90b8668bf1ae56a3720e400c75a3497"><gtr:id>a90b8668bf1ae56a3720e400c75a3497</gtr:id><gtr:otherNames>Ye J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1757-6512</gtr:issn><gtr:outcomeId>5a2fd8dc9396c3.24701363</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3B034EB-0C6C-4EA6-AD23-9A37D9D7CDF9</gtr:id><gtr:title>MiR-145 suppresses embryo-epithelial juxtacrine communication at implantation by modulating maternal IGF1R.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61b22fd142b550e7e1b873d06726a9af"><gtr:id>61b22fd142b550e7e1b873d06726a9af</gtr:id><gtr:otherNames>Kang YJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>56d9cd5cdd5452.26011916</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C92A08F8-CB3C-45A1-8C4E-A76B9C95E119</gtr:id><gtr:title>No common denominator: a review of outcome measures in IVF RCTs.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f9605c5e32e31e25cde9b73007beb93"><gtr:id>9f9605c5e32e31e25cde9b73007beb93</gtr:id><gtr:otherNames>Wilkinson J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn><gtr:outcomeId>58c2c273e41bc1.06220520</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52D89D00-AFE7-4A36-9753-FC7386C8CBF0</gtr:id><gtr:title>Generating cartilage repair from pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>Tissue engineering. Part B, Reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8bc25f202f0a7e25ac3d6deaad2005b"><gtr:id>d8bc25f202f0a7e25ac3d6deaad2005b</gtr:id><gtr:otherNames>Cheng A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1937-3368</gtr:issn><gtr:outcomeId>pm_15264_24_23957872</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>303C0A71-79B0-423C-972D-8C6B3BB2A225</gtr:id><gtr:title>Biological optimization, the Goldilocks principle, and how much is lagom in the preimplantation embryo.</gtr:title><gtr:parentPublicationTitle>Molecular reproduction and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc86168aa0009a12492b860b6e9a88c1"><gtr:id>bc86168aa0009a12492b860b6e9a88c1</gtr:id><gtr:otherNames>Leese HJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1040-452X</gtr:issn><gtr:outcomeId>58c2c27443da10.13072325</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F67D3801-BA11-4973-8354-E1A69ADDD60B</gtr:id><gtr:title>Elective Single Embryo Transfer: an update to UK Best Practice Guidelines.</gtr:title><gtr:parentPublicationTitle>Human fertility (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a14ab8d4d51dac3af2b2d3d0bb6f062"><gtr:id>2a14ab8d4d51dac3af2b2d3d0bb6f062</gtr:id><gtr:otherNames>Harbottle S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1464-7273</gtr:issn><gtr:outcomeId>56d9cc543d9a09.74142785</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2F5D227-48D9-49B5-8EEA-FBB37174E60F</gtr:id><gtr:title>Recombinant Laminins Drive the Differentiation and Self-Organization of hESC-Derived Hepatocytes.</gtr:title><gtr:parentPublicationTitle>Stem cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a58d69ad4f17dd544ce82aba3158212b"><gtr:id>a58d69ad4f17dd544ce82aba3158212b</gtr:id><gtr:otherNames>Cameron K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2213-6711</gtr:issn><gtr:outcomeId>585d405b846fd9.37529392</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20F891B0-E82F-4FC9-9FF6-533C5993A9B5</gtr:id><gtr:title>Embryo morphology as a predictor of IVF success: an evaluation of the proposed UK ACE grading scheme for cleavage stage embryos.</gtr:title><gtr:parentPublicationTitle>Human fertility (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db12c120e91a7fdacb8eca718fe5e7fd"><gtr:id>db12c120e91a7fdacb8eca718fe5e7fd</gtr:id><gtr:otherNames>Stylianou C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1464-7273</gtr:issn><gtr:outcomeId>56d9cc5310b6f8.23110781</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E681451-3772-4523-B69D-22137261891C</gtr:id><gtr:title>Current evidence for ART practice: the Cochrane of Cochranes on optimising outcomes.</gtr:title><gtr:parentPublicationTitle>Evidence-based medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6745dc9d496018514a97679b9b676727"><gtr:id>6745dc9d496018514a97679b9b676727</gtr:id><gtr:otherNames>Harper JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1356-5524</gtr:issn><gtr:outcomeId>546362cbe187f4.95407788</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B1D9C8D-9130-4717-AF4F-34A12FE53216</gtr:id><gtr:title>Testing for hypersensitivity to seminal fluid-free spermatozoa.</gtr:title><gtr:parentPublicationTitle>Human fertility (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/748e4b4c02ccd873019dbeba2f0eb633"><gtr:id>748e4b4c02ccd873019dbeba2f0eb633</gtr:id><gtr:otherNames>Carroll M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1464-7273</gtr:issn><gtr:outcomeId>546362cbbd47c1.98998652</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FECAFD4-530E-4447-A676-8D1508AB6453</gtr:id><gtr:title>Comparative proteomic analysis of supportive and unsupportive extracellular matrix substrates for human embryonic stem cell maintenance.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d992313132f7fc5b483dddbe10900065"><gtr:id>d992313132f7fc5b483dddbe10900065</gtr:id><gtr:otherNames>Soteriou D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_15264_24_23658023</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B239A0A-26C4-4E75-94EA-9A6D9F59E742</gtr:id><gtr:title>When and how should new technology be introduced into the IVF laboratory?</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17036ea8e84d55655caae17c174bef6a"><gtr:id>17036ea8e84d55655caae17c174bef6a</gtr:id><gtr:otherNames>Harper J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn><gtr:outcomeId>56d9cc55b64e91.50826940</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>938300C5-22DF-41BE-BAE4-52118889C1B1</gtr:id><gtr:title>ACE consensus meeting report: culture systems.</gtr:title><gtr:parentPublicationTitle>Human fertility (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/209bbf8a071fc6234a1542a2569ff08e"><gtr:id>209bbf8a071fc6234a1542a2569ff08e</gtr:id><gtr:otherNames>Bolton VN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1464-7273</gtr:issn><gtr:outcomeId>546362cc3f0169.93698456</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70EB00BA-5158-4444-918C-4FF3F374028E</gtr:id><gtr:title>Graphene Oxide promotes embryonic stem cell differentiation to haematopoietic lineage.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8bc335b9058c25ae59c2c91c49d66f3"><gtr:id>a8bc335b9058c25ae59c2c91c49d66f3</gtr:id><gtr:otherNames>Garcia-Alegria E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58bb1d9562b348.31302989</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0409054E-D54C-4F37-B8DF-A2BCA1A9D295</gtr:id><gtr:title>The procurement of cells for the derivation of human embryonic stem cell lines for therapeutic use: recommendations for good practice.</gtr:title><gtr:parentPublicationTitle>Stem cell reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0ae23803e6e96e9fac7081387c099d5"><gtr:id>f0ae23803e6e96e9fac7081387c099d5</gtr:id><gtr:otherNames>Murdoch A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1550-8943</gtr:issn><gtr:outcomeId>56d9cc54e47b64.23834938</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/J021636/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>A442BF36-F335-483E-9282-F3BB48AC2C47</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Cell biology</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>6723A70B-A523-40AB-9740-B6AD2A0677B7</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Medical &amp; health interface</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>FB535BD0-E265-4C0A-8532-32DCB83A3951</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Tools, technologies &amp; methods</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>D16FDB98-8CBA-4298-8ACD-955DF734E7F5</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Cells</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>F50F534E-2EE9-4970-AE8D-BAF7663379C5</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Development (Biosciences)</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>CF8D454F-63BF-45A6-8974-473A3150758A</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Stem cell biology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>195B48B4-2BC5-4DEB-BA1A-323A90D8730D</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Tissue engineering</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>